Rtog Foundation, Inc.
Clinical trials sponsored by Rtog Foundation, Inc., explained in plain language.
-
New hope for brain tumor patients: targeted radiation trial launches
Disease control TerminatedThis study tests a radioactive drug called Lu-177 DOTATATE in adults with progressive meningioma (a type of brain tumor). The goal is to see if it can slow tumor growth better than standard care. About 153 participants will be randomly assigned to receive the drug or continue usu…
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
New combo therapy aims to stall return of head and neck cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to precise, high-dose radiation (SBRT) can help people with head and neck cancer that has returned or is a new tumor in the same area. About 86 adults whose cancer cannot be removed by surgery will be…
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Can a drug combo stop prostate cancer from coming back?
Disease control OngoingThis study tests if adding a stronger hormone therapy (enzalutamide) to standard treatment helps men whose prostate cancer returned after surgery. About 188 men with aggressive signs will get radiation plus either standard or enhanced hormone therapy. The goal is to see if the en…
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 26, 2026 05:02 UTC